McKesson

Merge CAD partners with industry leaders to deliver the standard of care in MRI

Merge CAD and McKesson have integrated CADstream into the McKesson PACS. Physicians can access CADstream for reading from the PACS work-list.

Used by thousands of physicians throughout the world and supported by peer-reviewed research, CADstream is proven MRI-CAD. CADstream improves quality, standardization and efficiency of study analysis, reporting and interventional planning. As the most complete, full featured MRI-CAD system available, CADstream encompasses 7 years of product refinement. CADstream is optimized for fast, easy, reliable and integrated analysis and interpretation of studies.

Features include:

Rapid, automated and standardized processing algorithms

High quality diagnostic and interventional guidance tools

Efficient, easy-to-use user interface

2D/3D smart motion correction

Comprehensive kinetic tools

Morphology reporting tools

Seamless study comparison for patient monitoring

Instant access to previous studies through CADalog®, CADstream's study library

Advanced surgical planning, and therapeutic and patient monitoring reports

Accommodates 3T MRI and 1024 matrix studies*

Work-list level integration with industry-leading PACS and Penrad reporting system

SureLoc® for interventional guidance at point of procedure

*Only available with the CADstream Enterprise 3T system.

 

Recent News:

McKesson PACS: CADstream is now fully integrated at the work-list level into McKesson PACS further maximizing customer workflow.

CADstream applications: CADstream now offers applications for breast and prostate.

SureLoc compatibility: SureLoc is compatible with all biopsy coils and interventional systems.

Fully integrated with PACS: CADstream is now fully integrated at the work-list level into industry-leading PACS.

CADstream named the standard of care: CADstream was named the Standard of Care in breast MRI-CAD by Frost and Sullivan.

CADstream continues to be the MRI CAD system of choice: CADstream has been purchased by 38 of the top 50 cancer centers in the US.

Merge CAD continues to lead the CAD for MRI market: CADstream commands 65% of the breast MRI CAD market.